New York City, NY -- (SBWIRE) -- 12/02/2013 -- StockMarketIntel.com issues a special report on the following stocks: BlackBerry Ltd (NASDAQ:BBRY), Synovus Financial Corp. (NYSE:SNV), Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
BlackBerry Ltd (NASDAQ:BBRY) added 0.63% recently, while trading on 2.16 million shares at the price of $6.37. If we look at its trading history of the past 52 weeks, the share price suffered a low of $5.98 and was moved to its maximum level of $18.32.The stock changed hands in a range of $6.33 to $6.43, bringing its market capitalization at about $3.28 billion. BlackBerry Limited, formerly Research In Motion Limited, is a designer, manufacturer, and marketer of wireless solutions for the worldwide mobile communications market. Through the development of integrated hardware, software and services, it provides platforms and solutions for seamless access to information, including e-mail, voice, instant messaging, short message service (SMS), Internet and intranet-based applications and browsing.
Will BBRY Continue To Move Higher? Find Out Here
Synovus Financial Corp. (NYSE:SNV) added 1.43% recently, in the current trading session, at $3.54 with a total volume of 1.55 million shares. The stock, on average, trades on a volume of 5.93 million shares. In the past 52 weeks, the share price has not declined below $2.29 and above $3.54.It floated in a range of $3.49 to $3.54 during the recent trading session, with a beta value of 1.99.Its market capitalization now moved to about $3.44 billion. Synovus Financial Corp. ( Synovus) is a financial services and a bank holding company. The Company provides integrated financial services, including commercial and retail banking, financial management, insurance and mortgage services to its customers through 29 locally-branded banking divisions of its wholly-owned subsidiary bank, Synovus Bank, and other offices in Georgia, Alabama, South Carolina, Florida and Tennessee. Its retail banking services include accepting customary types of demand and savings deposits; mortgage, installment and other retail loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; Internet based banking services, and bank credit card services, including MasterCard and Visa services. In December 10, 2012, it sold the distressed assets.
What was the Moving Force behind SNV on Bullish Run? Read This Research Report
Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) recently added0.57% and was moving within a range of $5.12-$5.31. Its current trading price is $5.28. The share price hit its 52-week low of $1.62 and $8.77 was the best price. The stock completed the day with a total volume of 1.32 million shares, versus an average volume of 7.67 million shares. Yingli Green Energy Holding Company Limited is a vertically integrated photovoltaic (PV), product manufacturer worldwide. The Company designs, manufactures and sells PV modules, and design, assemble, sell and install PV systems. Its products and services substantially cover the entire PV industry value chain, ranging from crystalline polysilicon ingots and wafers, PV cells and PV modules to the manufacture of PV systems and the installation of PV systems.
For How Long YGE will fight for Profitability? Read This Trend Analysis report
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) added 6.70% in its current trading activity, bringing its market capitalization around $2.26 billion. The total number of shares that changed hands during the current session up till now was 797,098 shares, as compared to average trading volume of 1.93 million shares. The share price after opening at $23.29 made a high of $25.00 and hovered above $23.08, while its recent trading price was $24.86. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The Company has four product candidates in clinical development led by pimavanserin, which is in Phase III development as a first-in-class treatment for Parkinson's disease psychosis.
For How Long ACAD Gloss will Attract Investors? Find out via this report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)